Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05067088 · ClinicalTrials.gov registry record

Novel physIologiC prEdictors of Positive Airway Pressure Effectiveness

A clinical trial of Obstructive Sleep Apnea, sponsored by Yale University.

Active
Registry status
267
Enrollment target
1
Study location

NCT05067088: Active study of Obstructive Sleep Apnea, sponsored by Yale University.

NCT05067088 is a study of Obstructive Sleep Apnea that is active but no longer recruiting, run by Yale University. The registered enrollment target is 267 participants, above the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05067088, a study of Obstructive Sleep Apnea, is active but no longer recruiting, sponsored by Yale University.

ACTIVE NOT RECRUITING
Registry status
267 participants
Enrollment target
1
Study location

Study Summary

Millions of Americans suffer from high blood pressure, diabetes, strokes and motor vehicle accidents due to ineffective treatment of obstructive sleep apnea (OSA). Our preliminary data suggest that physiological causes of OSA such as easy arousability (low arousal threshold) or unstable breathing control (high loop gain) may influence effectiveness of OSA's most common treatment, continuous positive airway pressure (CPAP). The NICE-PAP study will examine how the physiologic traits that cause OSA in each individual impact CPAP effectiveness and can lead to personalized OSA treatments that improve patient lives.

Primary Outcome

average daily CPAP use (hours/night)

Conditions Studied

Interventions

  • OTHER CPAP (all patients receive CPAP as part of routine clinical care)

Study Locations (1)

Connecticut

  • Yale New Haven Hospital Sleep Center - North Haven

Trial Details

FieldValue
Enrollment Target 267 participants
Start Date 2022-01-01
Est. Completion 2026-08-28
Yale University

1,492 total trials

What the registry record for NCT05067088 still lists

NCT05067088 is an observational study that tracks outcomes without assigning an intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap, above the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (21% higher).

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which CPAP (all patients receive CPAP as part of routine clinical care) is the first listed.

NCT05067088 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT05067088 about?

NCT05067088 is a clinical study titled "Novel physIologiC prEdictors of Positive Airway Pressure Effectiveness". Millions of Americans suffer from high blood pressure, diabetes, strokes and motor vehicle accidents due to ineffective treatment of obstructive sleep apnea (OSA). Our preliminary data suggest that physiological causes of OSA such as easy arousability (low arousal threshold) or unstable breathing co...

What is the current status of trial NCT05067088?

This trial is currently active not recruiting. The enrollment target is 267 participants. The study started on 2022-01-01. Estimated completion is 2026-08-28.

What conditions does trial NCT05067088 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT05067088?

The interventions under investigation include: CPAP (all patients receive CPAP as part of routine clinical care) (OTHER).

Who is sponsoring clinical trial NCT05067088?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05067088 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05067088's enrollment target sits among peer trials

267 26th of 155 higher than 130 of 155 other Obstructive Sleep Apnea trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04997109 · 267 participants · NA

    Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

  • NCT05355701 · 267 participants · Phase 1

    A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

  • NCT06203509 · 267 participants · NA

    Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness

  • NCT05000632 · 268 participants · NA

    Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05067088, the US trial registry maintained by the National Library of Medicine. NCT05067088 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.